Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin + Ipamorelin Blend: Research Models Comparison

Age-related GH decline Peak GH amplitude restoration Moderate (1.8× baseline) Minimal (1.2× baseline) High (3.1× baseline) Blend replicates youthful pulsatile secretion. Essential for aging models Visceral adipose reduction % reduction in VAT mass 9% at 12 wee

This comparison does not assign a generated winner or score.

  • Age-related GH decline
  • Peak GH amplitude restoration
  • Moderate (1.8× baseline)
  • Minimal (1.2× baseline)
  • High (3.1× baseline)
  • Blend replicates youthful pulsatile secretion. Essential for aging models
  • Visceral adipose reduction
  • % reduction in VAT mass
  • 9% at 12 weeks
  • 6% at 12 weeks
  • 18% at 12 weeks
  • Synergistic lipolysis effect not seen with monotherapy
  • Lean mass preservation
  • Change in lean tissue mass
  • +3%
  • +2%
  • +7%
  • Dual IGF-1 upregulation plus protein synthesis signalling
  • Insulin sensitivity
  • HOMA-IR score change
  • No significant change
  • Slight improvement
  • Moderate improvement (−22%)
  • Pulsatile GH preserves insulin sensitivity vs continuous elevation
  • GH pulse duration
  • Hours of elevated plasma GH
  • 1.5–2 hours
  • 1–1.5 hours
  • 4–6 hours
  • Extended secretory window allows downstream metabolic effects to manifest
More references

Related material